Results 11 to 20 of about 18,393 (197)

Visual hallucinations associated with bupropion use: a case report

open access: yesPsychiatry and Clinical Psychopharmacology, 2021
Bupropion is an antidepresant that acts as a norepinephrine and dopamine reuptake inhibitor and has a favorable side-effect profile. The most common side-effects of this drug include insomnia, constipation, headache and dry mouth.
Sevda Korkmaz   +3 more
doaj   +1 more source

Filtrationsmembranen und spezifische Adsorber auf der Basis von maßgeschneiderten selbst‐organiserenden Blockcopolymeren Filtration Membranes and Specific Adsorbers on the Basis of Tailor‐Made Self‐Assembling Block Copolymers

open access: yesChemie Ingenieur Technik, Volume 95, Issue 9, Page 1361-1371, September 2023., 2023
Dieser Artikel beschreibt die Herstellung und Einsatzmöglichkeiten von isoporösen integral‐asymmetrischen Membranen aus maßgeschneiderten selbstorganisierenden Blockcopolymeren sowie das Potenzial maßgeschneiderter funktionalisierter Blockcopolymere als Phasentransfermaterialien für spezifische Extraktionen.
Volker Abetz
wiley   +1 more source

New generation antipsychotics in the treatment of schizophrenia: dopamine stabilizing agents and aripiprazole

open access: yesPsychiatry and Clinical Psychopharmacology, 2021
Schizophrenia is a major mental disorder starting mostly during adolescence and cause significant disability. Positive and negative symptoms and cognitive dysfunctions are main domains of schizophrenia. Dopaminergic hyperactivation in mesolimbic regions
Köksal Alptekin
doaj  

Loss of angiotensin II receptor expression in dopamine neurons in Parkinson’s disease correlates with pathological progression and is accompanied by increases in Nox4- and 8-OH guanosine-related nucleic acid oxidation and caspase-3 activation [PDF]

open access: yes, 2015
In rodent models of Parkinsons disease (PD), dopamine neuron loss is accompanied by increased expression of angiotensin II (AngII), its type 1 receptor (AT1), and NADPH oxidase (Nox) in the nigral dopamine neurons and microglia.
Aboud, O   +6 more
core   +2 more sources

Evaluating the antidepressant efficacy of aripiprazole using a chronic mild stress model: an experimental study

open access: yesPsychiatry and Clinical Psychopharmacology, 2021
Introduction: Aripiprazole is a partial agonist of dopamine D2 and D3 and serotonin 5-HT1A, 5-HT2C and 5-HT7 receptors, and it is also an antagonist of serotonin 5-HT2A and 5-HT6 receptors.
Ibrahim Eren   +2 more
doaj   +1 more source

Prolongation of hyperprolactinemia by clozapine: a case report

open access: yesPsychiatry and Clinical Psychopharmacology, 2021
Dopamine antagonism by antipsychotic drugs in the mesolimbic pathway leads to their therapeutic effect, while their D2 receptor antagonism in the tuberoinfindibular pathway causes hyperprolactinemia.
Esra Yancar Demir, Aslihan Sayin
doaj   +1 more source

Şizofreni psikofarmakolojisine giriş dopamin hipotezi

open access: yesPsychiatry and Clinical Psychopharmacology, 2021
-
Özcan Köknel
doaj  

CIB1 protects against MPTP-induced neurotoxicity through inhibiting ASK1. [PDF]

open access: yes, 2017
Calcium and integrin binding protein 1 (CIB1) is a calcium-binding protein that was initially identified as a binding partner of platelet integrin αIIb. Although CIB1 has been shown to interact with multiple proteins, its biological function in the brain
Choi, Eui-Ju   +8 more
core   +4 more sources

Aripiprazole: A new atypical antipsyhotic drug

open access: yesPsychiatry and Clinical Psychopharmacology, 2021
Aripiprazole is a new atypical antipsychotic with a distinct way of action from all currently available antipsychotic drugs. It acts on both postynaptic dopamine D2 receptors and presynaptic autoreceptors and is considered a partial dopaminergic agonist.
E. Serap Monkul, Berna Binnur Akdede
doaj  

Home - About - Disclaimer - Privacy